Singapore: +65-85097465 | India: +91-40-42023318
  U.S / Canada Toll Free: +1-866-259-4781
  Zimbabwe: +263-735539685, 773876488

          

Clinical Trial News

Ebola survivors' blood to undergo evaluation as treatment option

An EU-funded project to evaluate the safety and effectiveness of treatment with blood and plasma made from the blood of recovered Ebola patients is due to start soon in Guinea.

Long-term safety and efficacy of once-daily Zonegran® (zonisamide) monotherapy demonstrated in extension of pivotal study

Zonegran® (zonisamide) continues to be well-tolerated and efficacious when used as long-term montherapy for the treatment of partial onset seizures in adults with newly diagnosed epilepsy, as...

Were clinical trial practices in East Germany questionable?

Clinical trials carried out in the former East Germany in the second half of the 20th century were not always with the full knowledge or understanding of participants with some questionable...

Salix's TARGET 3 study examines the safety and efficacy of repeat treatment with Rifaximin for IBS with diarrhea

Salix Pharmaceuticals, Ltd. has announced that Dr. Anthony Lembo of Beth Israel Deaconess Medical Center will present the results of TARGET 3 in a late-breaking podium presentation at the American...

Exalenz Bioscience launches pivotal study of world's first breath-based test to diagnose clinically significant portal hypertension

Exalenz Bioscience, a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, announced the start of a pivotal...

Schizophrenia: data supporting the efficacy, safety and tolerability of once-daily Latuda® (lurasidone) presented at ECNP 2014

Takeda Pharmaceuticals International GmbH and Sunovion Pharmaceuticals Inc. presented new evidence supporting the use of Latuda® (lurasidone), an atypical antipsychotic treatment for adults...

Clinical trial demonstrates prolonged survival for advanced multiple myeloma patients

John Theurer Cancer Center at Hackensack University Medical Center has announced publication of breakthrough data in the treatment of advanced multiple myeloma in the journal Biology of Blood and...

Experts share their "real world" experience of treating people with Inflammatory Bowel Disease with biosimilar anti-TNFα monoclonal antibody (mAb)

Clinical experience presented at the Celltrion Healthcare satellite symposium during UEGW 2014 builds the evidence base for treating patients with IBD (Crohn's disease and ulcerative colitis) with...



James Lind Institute Newsletter
James Lind Institute Linkedin
James Lind Institute RSS
James Lind Institute Email Update
James Lind Institute Blog
James Lind Institute Facebook